Mitsubishi Chemical Q1 Results Down, Sees Higher Net Profit, Lower Revenues In H1, FY25; Stock Down

Mitsubishi Chemical Group reported a significant decline in Q1 net income, down 50.5% to 19.63 billion yen, and sales revenue, down 13.4% to 880.65 billion yen, prompting a 3.77% share price drop. Despite the weak start, the company projects a substantial full-year rebound, forecasting attributable profit to surge 222.1% to 145 billion yen and core operating income to rise 15.8% for fiscal 2025, even as it anticipates overall sales revenue to remain lower.

Analysis

Mitsubishi Chemical Group reported a sharply negative first quarter, with net income attributable to owners falling 50.5% to 19.63 billion yen and sales revenue declining 13.4% to 880.65 billion yen year-over-year. This performance miss triggered an immediate negative market response, with the company's shares falling 3.77% in Tokyo trading. In stark contrast to the current results, the company's forward guidance presents a disconnect between revenue and profitability. For the full fiscal year 2025, management projects attributable profit will surge by 222.1% to 145 billion yen and core operating income will increase 15.8%, even while forecasting a 5.3% decline in full-year sales revenue. This guidance implies a significant reliance on margin expansion, cost efficiencies, or other non-operational factors to drive earnings, creating a mixed outlook where severe current weakness is juxtaposed with highly optimistic profit recovery targets.

Key Decisions for Investors

• Investors should critically evaluate the drivers behind the projected 222.1% full-year profit growth, as it is forecast against a 5.3% decline in sales, suggesting potential reliance on non-core items or aggressive cost-cutting initiatives.
• The 3.77% share price decline following the weak Q1 results may present an entry point for investors who have high conviction in management's ability to execute its dramatic profit turnaround plan for fiscal 2025.
• Closely monitor the company's first-half results for early signs of the forecasted margin expansion, as any deviation from the guidance could significantly impact investor sentiment and stock performance.